Reducing Overdose and Stigma by Training Harm Reduction Champions
This study is testing a program called the Peer Harm Reduction Support Champion Intervention. It aims to reduce opioid overdoses and the negative feelings (stigma) associated with substance use. The program will train friends and family members who do not use opioids, but know someone who does, to become "harm reduction champions." These champions will learn about tools and services that can help prevent overdose and support people who use opioids. The study will look at how often overdoses happen, and how often people access harm reduction services and tools, over 6 months. This study is currently unclear on its recruitment status, and plans to enroll 600 participants.
- Study design
- This is an interventional study, meaning participants will receive a specific intervention. It plans to enroll 600 participants.
- What's involved
- Participants will be educated on harm reduction tools and services, and trained to become peer harm reduction support champions. They will be asked to recruit one friend or family member who uses opioids to the study. Participants will have measurements taken at baseline, 1 month, 3 months, and 6 months.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 6 months after starting the intervention.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Reducing Overdose and Substance Use-related Stigma by Training Non-substance-using Friends and Family Members of People Who Use Opioids to Be Harm Reduction Champions
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Leslie D. Williams, Ph.D. · PRINCIPAL_INVESTIGATOR · University of Illinois at Chicago
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Overdose Frequency and Experiencesbaseline, 1 month, 3 months, 6 months
Overdose frequency and experiences will be measured using participant self-report on items used by the Investigators in previous studies of PWUD. Items will ask about the number of overdoses participants experienced in the last three months (at baseline) and since the last interview (for follow-up). For each overdose reported, items will ask whether the participant was alone, whether naloxone was used, whether first responders were called, and whether an emergency room visit occurred. Participants will also be asked to report on whether they were present while someone else overdosed, and if so, whether they or someone else used naloxone.
- Number of Types of Harm Reduction Services Accessedbaseline, 1 month, 3 months, 6 months
This will be measured using participant self-report. Participants will be asked about their harm reduction service access and use in the last three months (at baseline) and since the last interview (for follow-up). Specifically, participants will be asked to report on how many times they accessed or received naloxone and fentanyl test strip kits, used fentanyl test strip kits, used "never use alone" hotlines, used "safe spaces" to use drugs or to experience withdrawal, used syringe service programs, tested for HIV or HCV, accessed medication for opioid use disorder, and accessed other types of drug treatment. A composite score will be computed reflecting the number of types of harm reduction tools and services accessed, which will be a count of all service/tool types accessed or used.
- Frequency of Access to Harm Reduction Tools and Servicesbaseline, 1 month, 3 months, 6 months
This will be measured using participant self-report. Participants will be asked about their harm reduction service access and use in the last three months (at baseline) and since the last interview (for follow-up). Specifically, participants will be asked to report on how many times they accessed or received naloxone and fentanyl test strip kits, used fentanyl test strip kits, used "never use alone" hotlines, used "safe spaces" to use drugs or to experience withdrawal, used syringe service programs, tested for HIV or HCV, accessed medication for opioid use disorder, and accessed other types of drug treatment. A composite score will be computed reflecting frequency of access to these tools and services, which will be a sum of the total number of times each participant used any of the harm reduction tools and services above.